J. H. Pedersen

Development and validation of a specific radioimmunoassay for PHI in plasma.

J. Fahrenkrug, J. H. Pedersen, J. Pedersen, 1984, Clinica chimica acta; international journal of clinical chemistry.

Preparation of 125I-(Tyr 3)- and 125I-(Tyr 11)- neurotensin for radioimmunoassay.

J. Fahrenkrug, F. Stadil, J. H. Pedersen, 1983, Scandinavian journal of clinical and laboratory investigation.

Neurotensin-like immunoreactivities in human plasma: Feeding responses and metabolism

J. Fahrenkrug, J. H. Pedersen, J. Pedersen, 1986, Peptides.

Fasting and meal-stimulated plasma levels of neurotensin in obese patients after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.

F. Stadil, T. Sørensen, B. Andersen, 1987, Scandinavian journal of gastroenterology.

Plasma levels of neurotensin in gastroplasty for morbid obesity

F. Stadil, J. Miskowiak, B. Andersen, 1984, Regulatory Peptides.

Cosecretion of peptide histidine methionine (PHM) and vasoactive intestinal peptide (VIP) in patients with VIP-producing tumors

J. Fahrenkrug, J. H. Pedersen, J. Pedersen, 1986, Peptides.

Pharmacokinetics and metabolism of neurotensin in man.

J. Henriksen, H. O. Andersen, J. H. Pedersen, 1989, The Journal of clinical endocrinology and metabolism.

Neurotensin induced inhibition of gastric acid secretion in duodenal ulcer patients before and after parietal cell vagotomy.

John R. Christiansen, J. Fahrenkrug, P. Kirkegaard, 1984, Gut.

Effect of neurotensin in the dumping syndrome.

A. Fischer, M. Shokouh-amiri, J. H. Pedersen, 1986, Scandinavian journal of gastroenterology.